DOCSLIB.ORG

2021-2025 Maryland Comprehensive Cancer Control Plan

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2021-2025 Maryland Comprehensive Cancer Control Plan 2021 2025 COMPREHENSIVE CANCER CONTROL PLAN INTRODUCTION t is my pleasure to introduce the 2021-2025 Maryland Rather, the plan is a call to action to encourage Comprehensive Cancer Control Plan. Cancer is a individuals or organizations involved in any aspect Idisease that affects the lives of many people in of cancer control to address one or more of the Maryland and is the second leading cause of death in objectives, and to apply the appropriate strategies and our state and in the nation. The newly updated 2021- resources as opportunities arise. 2025 Maryland Comprehensive Cancer Control Plan offers an opportunity to work together by continuing It is only through the collaborative efforts of to increase our efforts to reduce cancer risk, detect stakeholders across the state that we will succeed cancer early, improve treatment, and enhance in this fight against cancer. We look forward to your survivorship. participation and continued dedication to reducing the burden of cancer in Maryland. This plan is a framework for action and collaboration. It serves as a guide for health professionals, who Sincerely, are involved in planning, directing, implementing, evaluating, or performing research on cancer control Robert R. Neall in Maryland. It is also a resource for all Marylanders Secretary (individuals, health care providers, communities, and Maryland Department of Health organizations) on cancer control topics. The updated plan presents content in cross-cutting sections and topics, with a focus on goals, objectives, and strategies. Niharika Khanna, MD The purpose of the plan is to encourage collaboration Chair and cohesiveness among stakeholders as they work Maryland Cancer Collaborative toward reducing the burden of cancer in Maryland. Kevin Cullen, MD Representatives from the Maryland Department of Chair Health, Maryland Cancer Collaborative, Maryland State Maryland State Council on Cancer Control Council on Cancer Control, and cancer survivors and other experts in the state contributed to updating the plan. Collectively, the goals, objectives, and strategies are far-reaching and complex, and no one organization can carry out all these activities. Comprehensive Cancer Control Plan | Page 2 DEDICATION This Cancer Plan is dedicated to all the courageous Marylanders and their families who fight or have fought a battle against cancer. The Maryland Comprehensive Cancer Control Plan serves as a tribute to your valiant efforts. CHP 2| PAGE 3 Comprehensive Cancer Control Plan | Page 3 PAGE 3 MARYLAND COMPREHENSIVE CANCER CONTROL PLAN 2021 - 2025 Prepared by: Brian Mattingly Director Comprehensive Cancer Control Program Erica Smith, MS Deputy Director Center for Cancer Prevention and Control Pamela Williams, MHA Bureau Director Cancer and Chronic Disease Bureau Ken Lin Tai, MD, MPH Director Center for Cancer Prevention and Control Comprehensive Cancer Control Plan | Page 4 TABLE OF CONTENTS 6 ACKNOWLEDGMENTS 64 SE CTION 2: HIGH BURDEN CANCERS IN MARYLAND 7 CONTRIBUTORS 65 Priority Cancers in Maryland 79 Childhood Cancer 11 MARYLAND CANCER 81 Cross-Cutting Topics COLLABORATIVE 82 Patient Navigation 83 Patient-Level Education 12 MARYLAND COMPREHENSIVE 84 Health Care Provider Education CANCER CONTROL PLAN 85 Quality Monitoring and Improvement 87 Cancer Genetics 16 Key Terms and Acronyms Used in the Cancer Plan 92 Immunotherapy 20 Surveillance and Cancer Data Used in 93 Personalized Medicine the Cancer Plan 93 Research and Clinical Trials 22 Special Topics in Cancer Control 96 Goals, Objectives, and Strategies 22 Access to Health Care 24 Cancer Disparities 102 SE CTION 3: CANCER SURVIVORSHIP, PALLIATIVE 31 SE CTION 1: PRIMARY CARE, AND HOSPICE CARE PREVENTION OF CANCER 104 Survivorship 32 Tobacco Use 111 Palliative Care 38 Healthy Weight, Nutrition, and Physical Activity 113 Hospice Care 41 Alcohol Consumption 114 Goals, Objectives, and Strategies 41 Infections and Cancer Prevention Vaccines 45 Family History of Cancer 45 Cancer Chemoprevention for 119 APPENDICES High-Risk Populations 119 Sources of Maryland Data 45 Ultraviolet Radiation Exposure 120 Sources of National Data 48 Environmental/Occupational Issues 121 Data Considerations and Cancer 54 Goals, Objectives, and Strategies Table of Contents | Page 5 ACKNOWLEDGMENTS The updated 2021-2025 Maryland Comprehensive Cancer Control Plan represents a collaborative effort involving individuals and organizations from across the state of Maryland, including many members of the Maryland Cancer This publication was Collaborative. Cancer Plan contributors donated their time, expertise, and experience, and sincere thanks must go to those supported by Grant individuals who helped to draft sections of the Cancer Plan, as well as to those who reviewed drafts and provided feedback 1NB01OT009297-01 to the Maryland Department of Health Center for Cancer Prevention and Control. A list of individuals who contributed to and Cooperative the development of this updated Cancer Plan can be found on the following pages. Agreement 6NU58DP006333-04, In addition, various offices within the Maryland Department of Health contributed staff expertise and resources during the funded by the Centers Cancer Plan updating process, including: for Disease Control • Center for Cancer Prevention and Control • Center for Tobacco Prevention and Control and Prevention. Its • Center for Chronic Disease Prevention and Control contents are solely • Environmental Health Bureau • Infectious Disease Prevention and Health Services Bureau the responsibility of The collaborative efforts exerted in this process were integral the authors and do to updating the Cancer Plan. This same collaboration will continue to be vital as we work to implement the strategies not necessarily of the Cancer Plan and to impact the burden of cancer in Maryland. represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. Comprehensive Cancer Control Plan | Page 6 CONTRIBUTORS CLEMENT A. ADEBAMOWO, BM, CHB, SCD, CINDY CARTER FWACS, FACS Executive Director Assistant Director of Population Science and Cancer Support Foundation Director for Global Health Cancer Research Greenebaum Comprehensive Cancer Center Institute of Human Virology University of Maryland School of Medicine DAWN BERKOWITZ, MPH, CHES GEOFF COLEMAN, MD, MHA Director Chief Medical Director Maryland Center for Tobacco Prevention and Control Montgomery Hospice and Prince George’s Hospice Maryland Department of Health ALANNA BIBLOW, MPH, CHES JOCELYN COLLINS Project Coordinator Maryland and Washington, D.C. Government Maryland Center for Tobacco Prevention and Control Relations Director Maryland Department of Health American Cancer Society Cancer Action Network CHRISTINE BOYD, MPH KATHLEEN CONNORS-JURAS Overdose Data to Action Program Manager Cancer Control Strategic Partnerships Manager Office of the Deputy Secretary, Public Health Services American Cancer Society Maryland Department of Health OTIS W. BRAWLEY, MD, MACP, FASCO, FACE DONNA COSTA, MA, MHS Bloomberg Distinguished Professor of Oncology Oncology Outreach Manager and Epidemiology University of Maryland, St. Joseph Medical Center Johns Hopkins University JOSEPH BRODINE, MD, MPH CARLO DICLEMENTE, PH.D. Preventive Medicine Resident Emeritus Professor of Psychology Johns Hopkins University University of Maryland Family Medicine Resident Baltimore County, MD Quit Franklin Square XUEFANG CAO, PHD CINDY DOMINGO Co-Leader of the Tumor Immunology and Direct Services Lead Immunotherapy Program Cancer Screening Programs Unit University of Maryland School of Medicine Maryland Center for Cancer Prevention and Control Maryland Department of Health Comprehensive Cancer Control Plan | Page 7 JOANNE EBNER, RN, BSN, TTS MARIA GERONIMO, MBA, MSN, RN Supervisor Thoracic Program Coordinator Cancer Prevention/Nicotine Dependence Anne Arundel Medical Center Anne Arundel Medical Center DeCesaris Cancer Center KIRA EYRING SARAH GIERHART, MS Cancer Control Strategic Partnerships Manager Senior Epidemiologist American Cancer Society Maryland Center for Cancer Prevention and Control Maryland Department of Health CARMI WASHINGTON FLOOD SHILPA GOPINATH, MPH Chief, Office of Faith-Based and Community Public Health Applications for Student Experience Partnerships Intern (Spring 2020) Infectious Disease Prevention and Johns Hopkins Bloomberg School of Public Health Health Services Bureau Maryland Department of Health PATRICIA FORD, RN, MPH DONNA GUGEL, MHS Volunteer Director Leukemia and Lymphoma Society Maryland Prevention and Health Promotion Administration Maryland Department of Health SUZI FORD JENNIFER HAYES, MED, MPH Cancer Control Strategic Partnerships Manager Senior Epidemiologist American Cancer Society Maryland Cancer Registry Maryland Department of Health NANCY FORLIFER HOLLY HAYMAN, DNP, RN Director Community Wellness Director of Clinical Services UPMC Western Maryland Compass Regional Hospice and The Hope and Healing Center PEGGY FUNK, CAE KATHY HOWELL, CMI Executive Director Medical Interpreter/Cultural Consultant Hospice and Palliative Care Network of Maryland KMH Interpreting, Translation and Cultural Consulting PAUL GALONSKY, MPA NIKARDI JALLAH, MPH Quality Improvement Specialist Epidemiologist Maryland Center for Cancer Prevention and Control Maryland Center for Tobacco Prevention and Control Maryland Department of Health Maryland Department of Health Comprehensive Cancer Control Plan | Page 8 MARY JOSEPH, RN, BC, CPHQ THUY NGUYEN, MPH Project Manager Health Educator Primary Care
Load more

Recommended publications
  • Sales and Use Tax List of Tangible Personal Property and Services
    LIST OF TANGIBLE PERSONAL PROPERTY AND SERVICES SUBJECT TO SALES AND USE TAX Published by THE COMPTROLLER OF MARYLAND JULY 1, 2021 0 Table of Contents A. Taxable Services ........................................................................................................................... 4 B. Nontaxable Services ..................................................................................................................... 5 A. Aircraft ......................................................................................................................................... 6 B. Accommodations ......................................................................................................................... 6 C. Agricultural and Farming Supplies and Equipment ........................................................................ 7 D. Baby and Children’s Supplies ........................................................................................................ 8 E. Books, Magazines, Newspapers and Other Paper Products ........................................................... 9 F. Caterers ..................................................................................................................................... 11 G. Clothing, Footwear and Accessory Items ..................................................................................... 13 H. Computer Hardware and Software ............................................................................................. 14 I. Construction Materials ..............................................................................................................
    [Show full text]
  • Plain Packaging of Tobacco Products
    Plain packaging of tobacco products EVIDENCE, DESIGN AND IMPLEMENTATION Plain packaging of tobacco products EVIDENCE, DESIGN AND IMPLEMENTATION Contents Executive summary vii WHO Library Cataloguing-in-Publication Data Introduction 1 Plain packaging of tobacco products: evidence, design and implementation. Part 1. Plain packaging: definition, purposes and evidence 3 1.1 A working definition of plain packaging 4 1.Tobacco Products. 2.Product Packing. 3.Tobacco Industry – legislation. Purposes of plain packaging 8 4.Health Policy. 5.Smoking – prevention and control. 6.Tobacco Use – 1.2 prevention and control. I.World Health Organization. 1.3 The evidence base underlying plain packaging 10 1.3.1 The attractiveness of tobacco products and the advertising function of branding 11 ISBN 978 92 4 156522 6 (NLM classification: WM 290) 1.3.2 Misleading tobacco packaging 12 1.3.3 The effectiveness of health warnings 13 1.3.4 The prevalence of tobacco use 13 © World Health Organization 2016 1.3.5 Expert reviews of the evidence 15 1.3.6 Conclusions 18 All rights reserved. Publications of the World Health Organization are Additional resources 19 available on the WHO website (http://www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; Part 2. Policy design and implementation 21 email: [email protected]). 2.1 The policy design process 22 2.2 Implementation of plain packaging 25 Requests for permission to reproduce or translate WHO publications 2.3 Compliance and enforcement 32 –whether for sale or for non-commercial distribution– should be 2.3.1 Delayed compliance and penalties for non-compliance 33 addressed to WHO Press through the WHO website (http://www.who.int/ 2.3.2 Sleeves, stickers, inserts and other devices 34 about/licensing/copyright_form/index.html).
    [Show full text]
  • Maryland Medicaid Tobacco Cessation Coverage
    Maryland Medicaid Tobacco Cessation Coverage Why should standard Medicaid cover tobacco cessation? The Medicaid population smokes at a rate almost two and a half times higher than the private insurance population (23.9 percent vs. 10.5 percent)1. This high smoking rate not only leads to disease and premature death, but also costs the Medicaid program approximately $39.6 billion per year. That makes up nearly 15 percent of all annual Medicaid spending2. Investments to reduce smoking among the Medicaid population can lead to reductions in general healthcare costs and short-run Medicaid costs. Tobacco cessation can also save state Medicaid programs money over the long term. Comprehensive Recent research suggests that if just 1 percent of current smokers in Cessation Benefit: Maryland quit smoking, the state would save $53.6 million in Medicaid costs the following year3. Seven Medications: The seven medications and two forms of counseling discussed in the MMWR NRT Gum (OTC*) are proven effective tobacco cessation treatments. Improving access to these NRT Patch (OTC) NRT Lozenge (OTC) treatments can encourage more beneficiaries to quit smoking, which would NRT Inhaler result in substantial savings for the state. See how your state’s cessation NRT Nasal Spray coverage has improved in the tables below. Bupropion Medications Varenicline Three Forms of The Affordable Care Act requires all Medicaid enrollees to have access to all Counseling: seven cessation medications. Despite this requirement, coverage varies by state. States can impose barriers such as cost-sharing, prior authorization and Individual stepped care therapy. States that have Medicaid Managed Care plan can Group require all managed care plans to cover these medications.
    [Show full text]
  • Bill 31-19, Health and Sanitation- Electronic Cigarettes - Distribution, Use, and Possession Resolution to Adopt Bill 31-19 As a Board of Health Regulation 1
    HHS ITEM2 November 25, 2019 Worksession MEMORANDUM November 20, 2019 TO: Health and Human Services Committee FROM: Amanda Mihill, Legislative Attorney~ SUBJECT: Bill 31-19, Health and Sanitation- Electronic Cigarettes - Distribution, Use, and Possession Resolution to adopt Bill 31-19 as a Board of Health regulation 1 PURPOSE: Worksession- Committee to make recommendations on Bill and Resolution Bill 31-19, Health and Sanitation- Electronic Cigarettes - Distribution, Use, and Possession and a Resolution to adopt Bill 31-19 as a Board of Health regulation, sponsored by Lead Sponsors Councilmembers Hucker and Albornoz and Co-Sponsors, Councilmember Rice, Council Vice President Katz, Councilmembers Riemer, Glass, Jawando, and Council President Navarro was introduced on September 24, 2019. The corresponding Board of Health regulation was introduced on October 1, 2019. A public hearing was held on November 5 on this bill, ZTA 19-06, Vape Shops, along with related Bills 29-19 and 32-19 and their companion resolutions adopting each Bill as a Board of Health regulation. Bill 31-19 and the Regulation would prohibit the distribution of any tobacco product, coupon redeemable for a tobacco product, cigarette rolling paper, or electronic cigarette to any individual under 21 except under certain circumstances. It would also prohibit an individual under 21 from using or possessing a tobacco product or electronic cigarette except under certain circumstances. Public Hearing/Correspondence The Council held a public hearing on November 5 on Bill 31-19 and its companion regulation as well as related Bills 29-19 and 32-19 and ZTA 19-06. It was a joint hearing and most written testimony submitted on these bills is attached to the staff report of Bill 29- I 9.
    [Show full text]
  • Maryland County Smoking Cessation Programs
    State of Maryland 1-800-Quit Now SmokingStopsHere.com Allegany County Department of Health – Tobacco Cessation Program Kathy Dudley 301-759-5050 (ph) 301-777-2098 (fax) [email protected] (email) PO Box 1745 12503 Willowbrook Rd Cumberlans, MD 21501 Anne Arundel County Department of Health – Quit Smoking Help Learn to Live Information Line and Websites 410-222-7979 (ph) 410-222-4067 (fax) www.MyQuitKit.org www.LearnToLiveHealthy.org [email protected] (email) 1 Harry S. Truman Parkway Annapolis, MD 21401 Baltimore City Department of Health – Tobacco Use Prevention and Cessation Program Letta Grant 410-361-9765 Community Health Educator, Tobacco Free Baltimore, Baltimore City Health Dept 7 E Redwood St, 2nd Floor Baltimore, MD 21201 [email protected] (email) Baltimore County Department of Health – Quit Smoking Help Vicki Pfannenstein 410-887-3828 Prevention & Tobacco Programs Manager Baltimore County Dept of Health Bureau of Behavior Health [email protected] (email) Calvert County Department of Health – Smoking Cessation Program Jane Dodds 410-535-5400 (ph) press 0 for the operator and ask for Jane Dodds 410-535-1955 (fax) [email protected] (email) PO Box 980 975 Solomon’s Island Rd North Prince Frederick, MD 20678 Caroline County Department of Health – Tobacco Cessation Program Heather Grove, RN BSN 410-479-8080 (ph) 410-479-2014 (fax) [email protected] (email) 403 S.7th St Denton, MD 21629 Wellness Room #268 Individual Counseling: Series of 6 lessons in person and follow-up contact for maintenance Offered selected dates and times Carroll County Department of Health – Cigarette Restitution Fund Program Barbara White 410-876-4443 (ph) 410-876-5990 (fax) [email protected] (email) Anne Grauet 410-876-4429 (ph) 410-876-5990 (fax) [email protected] (email) 290 S.
    [Show full text]
  • 'We're Not Gonna Have a Big Quit If Loose Ones Are Around': Urban
    HEALTH EDUCATION RESEARCH ‘We’re not gonna have a big quit if loose ones are around’: urban, African American smokers’ beliefs concerning single cigarette use reduction Downloaded from https://academic.oup.com/her/advance-article/doi/10.1093/her/cyab014/6343133 by guest on 01 October 2021 Lilianna Phan1*, Charlene Chao-Li Kuo2, Craig S. Fryer2,3, Mia A. Smith-Bynum4, Pamela I. Clark2 and James Butler III2 1Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA, 2Department of Behavioral and Community Health, University of Maryland School of Public Health, College Park, MD 20742, USA, 3Maryland Center for Health Equity, University of Maryland School of Public Health, College Park, MD 20742, USA and 4Department of Family Science, University of Maryland School of Public Health, College Park, MD 20742, USA *Correspondence to: L. Phan. E-mail: [email protected] Received on July 28, 2020; editorial decision on February 26, 2021; accepted on March 2, 2021 Abstract These findings can inform enforcement policies and health education interventions targeting Single cigarette use (i.e. loosies, loose ones, single cigarette use among urban, African singles) poses risks for smoking continuation American smokers who use singles. among urban, African American smokers. There is, however, limited research to inform health education interventions addressing this Introduction behavior. We conducted 25 in-depth interviews with urban, African American users (ages Overall, the smoking rate among U.S. adults has 20–58 years) from Baltimore, MD and the declined; however, racial and ethnic tobacco-related District of Columbia in June and July 2018 to as- disparities persist [1].
    [Show full text]
  • What Is the Tobacco Settlement? in the Mid 1990S, Many States Sued Cigarette Companies Like Philip Morris and R.J
    What is the Tobacco Settlement? In the mid 1990s, many states sued cigarette companies like Philip Morris and R.J. Reynolds for deceptive practices in making and marketing cigarettes. Some of these practices included deliberately making cigarettes more addictive and deadly while intentionally misrepresenting the risks. The states sought court orders modifying the companies' marketing practices and money damages to pay for increased medical costs caused by tobacco-related diseases. In 1998, the companies and states entered into a comprehensive settlement of all these claims, requiring the companies to change their marketing practices and pay billions of dollars to the states over time. This settlement is called the Tobacco Master Settlement Agreement. Since 1998, many other tobacco companies have joined the Master Settlement Agreement. They voluntarily agreed to the settlement's marketing restrictions and obligation to make ongoing payments. Some cigarette companies have not joined the settlement, but are obligated to comply with state laws that have some similar provisions. How are the settlement payments calculated? The annual settlement payments are based on the total volume of cigarettes sold in the United States, as determined by the number of cigarettes subject to the federal government's cigarette excise tax. Therefore, if the companies sell fewer cigarettes, their annual settlement payments decrease. The payments may also decrease if the companies that settled lose significant market share to cigarette companies that did not settle. However, the payments are adjusted upward for inflation at a rate not lower than 3% compounded annually. If inflation is over 3%, the inflation adjustment matches the overall inflation rate.
    [Show full text]
  • It's the Law It's The
    IT’S THE LAW IT’S THE LAW MARYLAND LAWS LICENSING REQUIREMENTS Sale and Distribution Retailers selling cigarettes, other tobacco products, or ENDS (Electronic • Tobacco products may ONLY be sold to individuals age 18 or older. Md. Ann. Code Crim. Law Nicotine Delivery Systems, e-cigarettes, vapes) must secure a license §10-107 and Md. Ann. Code Health- General § 24-307 from the clerk of the Circuit Court for the jurisdiction in which the retailer is located. Licenses expire on April 30th and must be renewed annually. • The sale of tobacco products in vending machines is prohibited unless the vending machine is located in an adult-only (age 18 or older) establishment. Md. Ann. Code • If a retailer sells cigarettes, they must obtain a license to do so. Bus. Reg. §16-3A-O2 • If a retailer sells cigarettes and other tobacco products, they must • Cigarettes may ONLY be sold in packages of at least 20. Md. Ann. Code Comm. obtain an endorsement to sell other tobacco products (at no additional Law §11-5A-O2 cost), in addition to the requisite cigarette license. • If a retailer sells other tobacco products and does not sell cigarettes, • The sale of clove cigarettes is prohibited. Md. Ann. Code Crim. Law §10-106 they must obtain a specific license to do so. • Electronic cigarettes; component parts; liquid nicotine; or products used to refill or • If a retailer sells ENDS and cigarettes or other tobacco products, they resupply an electronic cigarette may ONLY be sold to individuals 18 and older. do not need to obtain an additional license to sell ENDS.
    [Show full text]
  • The Impact of Plain Packaging and Health Warnings on Consumer Appeal of Cannabis Products T
    Drug and Alcohol Dependence 205 (2019) 107633 Contents lists available at ScienceDirect Drug and Alcohol Dependence journal homepage: www.elsevier.com/locate/drugalcdep Full length article The impact of plain packaging and health warnings on consumer appeal of cannabis products T Samantha Goodman, Cesar Leos-Toro, David Hammond* School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, N2L 3G1, Canada ARTICLE INFO ABSTRACT Keywords: Background: Canada implemented ‘plain packaging’ regulations and rotating health warnings for cannabis Cannabis products upon legalizing non-medical cannabis in October 2018. Plain packaging and health warnings are ef- Marijuana fective policy measures for reducing appeal of tobacco products; however, there is little evidence in the cannabis Packaging domain. Labeling Methods: An experimental task was conducted as part of the online International Cannabis Policy Study. Health warning Participants aged 16–65 from Canada (n = 9987) and US states with ‘legal’ (n = 7376) and ‘illegal’ (n = 9682) recreational cannabis were randomly assigned to see one of 18 cannabis product images. Outcomes were product appeal (0 = Not at all appealing, 10 = Very appealing) and perceived youth orientation (4 age groups). A 3 (branding: full branding, brand logo only, or plain black packaging) x 2 (health warning labels: present or absent) x 3 (product type: edible gummies, cannabis oil, or pre-rolled joints) factorial design was used. Results: Compared to plain packaging or a brand logo, packages with full branding were considered more ap- pealing and more likely to be youth-oriented (p < 0.001). Products with health warnings were considered less appealing than packages without warnings (p < 0.001).
    [Show full text]
  • Electronic Smoking Devices
    State and Local Policy Options Electronic Smoking Devices Electronic Smoking Devices (“ESDs”) are battery operated devices designed to heat a liquid nicotine solution to the point of vapor in order to deliver vapor the user for inhalation, mimicking the act of smoking. ESDs first began appearing widely in the United States in about 2006, and use and availability have significantly increased since.1 ESD sales have doubled every year since 2008, and are projected to approach $2 billion in 2013.2 At the same time, the Centers for Disease Control and Prevention (“CDC”) reported that ESD use among students in grades 6-12 more than doubled between 2011 and 2012 – the first years for which data is available – to an estimated 1.8 million students.3 These trends are concerning due to unanswered questions about the health risks arising from ESD use, including both negative health risks resulting from inhaling ESD vapor and broader negative health consequences at the population level. With respect to individual negative biological risks from inhaling vapor, studies have indicated that ESDs cause airway constriction in users and that inhaled and exhaled aerosol contain a number of the same carcinogens found in cigarettes.4 At the population level, ESDs complicate enforcement of existing prohibitions on smoking indoors, diminish those prohibitions’ secondary impact of cessation of tobacco use, and impede progress in social norm change related to smoking.5 These concerning trends are compounded by a lack of accurate data on ESDs due to their short time on the market and the lack of any meaningful quality control or product standards.
    [Show full text]
  • “Tobacco Products?” License Required to Sell Esds?
    1 License Required ESDs Included in the License Cost of Tobacco State for License Suspension or Revocation Provisions* required to Retailer License Definition of Tobacco “Tobacco Products?” sell ESDs? Retailer? Privilege license AND (a) Subject to the Alabama Administrative Procedure Act, Chapter 22 of Title 41, the board shall have full and tobacco permit required. final authority as to the suspension or revocation for cause of any permit issued pursuant to this chapter. … Privilege License (varies (b) The board, or a hearing commission appointed by the board, upon finding that a permit holder or any partner, by city size): member, employee, officer, or director of the permit holder has violated any of the laws of this state or the - 25,000 or more: $15 United States relating to the manufacture, sale, possession, or transportation of tobacco or tobacco products or AL - 10,000-25,000: $10 that the permit holder has acted in a manner prejudicial to the welfare, health, peace, temperance, and safety of - 5,000-10,000: $5 the people of the community or of the state, may upon due notice and hearing, levy administrative fines or ENDS Defined: Ala. Code § 28- - 2,000-5,000: $3 suspend or revoke the permit issued by the board, or a combination of all three. Ala. Code § 28-11-2(5) 11-7 (2019) - All other places: $2 Ala. Code § 28-11-9 Ala. Code § 40-12-72 Tobacco Permit: No fee Ala. Code § 28-11-7 Cigarettes: Cigarette The department may suspend, revoke, or refuse to renew a license issued under this chapter (1) for a negligent license and business violation of AS 11.76.100 [sales to minors], 11.76.106 [selling tobacco outside controlled access], 11.76.107 license endorsement [failure to supervise cigarette vending machine], or a violation of this chapter or a regulation of the required.
    [Show full text]
  • 1 Maryland Flavored Tobacco
    Maryland Flavored Tobacco Ban: Unnecessary, Costly, and Dangerous to Public Health David R. Hancox, CIA, CGFM (Ret.) I. Introduction My name is David Hancox, and I am the former Director of State Audits in the Office of the New York State Comptroller. I also was Director of State Expenditures in that Office. In total, I had 37 years of service with the State of New York. I am a retired Certified Internal Auditor and Certified Government Financial Manager. I’ve also written and taught extensively on a wide array of issues focused on government performance auditing, which relates to an assessment of planning, implementing, and managing government programs and policies, such as that before you now. At the outset, a few points are in order. First, R. J. Reynolds Tobacco Company has compensated me for my time in preparing these comments, but, second, the opinions expressed are my own. Third, I am not a user of tobacco products, I am not an advocate for using tobacco, and I believe smokers of traditional cigarettes should quit. That said, I would expect that my analytic approach is similar to what your Legislative Auditor, Mr. Gregory Hook, and his staff might do in preparing for a performance audit on the implementation of the proposed legislation before you now. An outright ban on the sale of all flavored tobacco products will be detrimental to your State and its residents. The fiscal impact on the State budget in a time of unprecedented financial crisis is underestimated in the Committee’s Fiscal and Policy note on this bill.
    [Show full text]